Immune Thrombocytopenia Pipeline

View All

Immune Thrombocytopenia Market
R&D and Upcoming therapies Paving the Way for a Potential and Better Cure for Immune Thrombocytopenia

The Immune Thrombocytopenia market size in the 7MM was estimated to be approximately USD 2,527.72 million in 2017. The US accounts for the largest ITP Market size. A disorder that results in an isolated low platelet count, Immune thrombocytopenia (ITP), is an autoimmune disorder that results in convincing body...

Find More